Skip to main content


HPV Prevention

Guest edited by: Dr Silvia de Sanjose

Human Papilloma Virus (HPV) is a major leading cause of Human Cancer. Through this series we would like to highlight the quality and the breadth of the research being carried out on the Control and Prevention of HPV and HPV related disease. This series aims to bring together a diverse range of HPV related specialities featuring research that has as ultimate goal insights into HPV related disease reduction. Articles can have a wide range of topics such as those of natural history studies, impact of screening interventions or impact of HPV vaccines will be most welcome.

Relevant research papers published in Infectious Agents and Cancer will be added to the series, with commentary to explain their significance, or put them in context for no specialist readers.

The section includes:

  • News on HPV research, highlight of events or articles that deserve particular attention for their relevance or controversy
  • A major research article on HPV with priority for community trials or demonstration projects of preventive strategies
  • A collection of relevant articles that relate to HPV disease reduction.

This collection of articles has not been sponsored and articles have undergone the journal's standard peer-review process and the Guest Editor declares no competing interest.

View all collections published in Infectious Agents and Cancer.

  1. Letter to the Editor

    HPV vaccines and cancer prevention, science versus activism

    The rationale behind current worldwide human papilloma virus (HPV) vaccination programs starts from two basic premises, 1) that HPV vaccines will prevent cervical cancers and save lives and, 2) have no risk of...

    Lucija Tomljenovic, Judy Wilyman, Eva Vanamee, Toni Bark and Christopher A Shaw

    Infectious Agents and Cancer 2013 8:6

    Published on: 1 February 2013

  2. Research article

    Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease

    Information on human papillomavirus (HPV) type distribution is necessary to evaluate the potential impact of current and future HPV vaccines. We estimated the relative contribution (RC) to invasive cervical ca...

    Beatriz Serrano, Laia Alemany, Sara Tous, Laia Bruni, Gary M Clifford, Thomas Weiss, Francesc Xavier Bosch and Silvia de Sanjosé

    Infectious Agents and Cancer 2012 7:38

    Published on: 29 December 2012

  3. Editorial

    HPV Prevention series

    Human Papilloma Virus (HPV) is a major leading cause of Human Cancer. Through the HPV Prevention series we would like to highlight the quality and the breadth of the research being carried out on the Control a...

    Silvia de Sanjosé

    Infectious Agents and Cancer 2012 7:37

    Published on: 20 December 2012

  4. Review

    HPV - immune response to infection and vaccination

    HPV infection in the genital tract is common in young sexually active individuals, the majority of whom clear the infection without overt clinical disease. However most of those who develop benign lesions even...

    Margaret Stanley

    Infectious Agents and Cancer 2010 5:19

    Published on: 20 October 2010

  5. Commentary

    The evolving definition of carcinogenic human papillomavirus

    Thirteen human papillomavirus (HPV) genotypes have been judged to be carcinogenic or probably carcinogenic, and the cause of virtually all cervical cancer worldwide. Other HPV genotypes could possibly be invol...

    Philip E Castle

    Infectious Agents and Cancer 2009 4:7

    Published on: 11 May 2009

  6. Research article

    Prevalence of human papillomavirus genotypes and their variants in high risk West Africa women immigrants in South Italy

    The distribution of human papillomaviruses (HPVs) varies greatly across populations and HPV surveys have been performed in different geographical regions in order to apply appropriate vaccine strategies. Littl...

    Maria Lina Tornesello, Maria Luisa Duraturo, Luigi Buonaguro, Gabriele Vallefuoco, Roberto Piccoli, Stefano Palmieri and Franco M Buonaguro

    Infectious Agents and Cancer 2007 2:1

    Published on: 3 January 2007